We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

162 hedge funds and large institutions have $629M invested in Emergent Biosolutions in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 57 increasing their positions, 57 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 14

1.73% more ownership

Funds ownership: 77.92% → 79.65% (+1.7%)

1% more funds holding

Funds holding: 160 → 162 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 57

4% less capital invested

Capital invested by funds: $655M → $629M (-$25.3M)

Holders
162
Holders Change
+2
Holders Change %
+1.25%
% of All Funds
4.7%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
57
Reduced
57
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FMA
Fiduciary Management Associates
Illinois
+$14.9M
2
GC
Guggenheim Capital
Illinois
+$9.07M
3
GPP
Great Point Partners
Connecticut
+$6.64M
4
KCM
Kennedy Capital Management
Missouri
+$6M
5
CM
Castleark Management
Illinois
+$4.13M

Top Sellers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
-$14.3M
2
PAM
Panagora Asset Management
Massachusetts
-$5.33M
3
GAM
Gotham Asset Management
New York
-$4.99M
4
Morgan Stanley
Morgan Stanley
New York
-$3.44M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Advisers
51
Two Sigma Advisers
New York
$2.14M -$195K -8,500 -8%
CAM
52
ClariVest Asset Management
California
$2.09M +$82.6K +3,606 +4%
VOYA Investment Management
53
VOYA Investment Management
Georgia
$2.07M -$216K -9,421 -9%
GC
54
Globeflex Capital
California
$2M -$86.3K -3,769 -4%
NFA
55
Nationwide Fund Advisors
Ohio
$1.96M +$5.08K +222 +0.2%
MCM
56
Matarin Capital Management
New York
$1.81M -$17K -743 -0.9%
MAA
57
Managed Account Advisors
New Jersey
$1.78M +$474K +20,690 +33%
ERSOT
58
Employees Retirement System of Texas
Texas
$1.66M – – –
Wellington Management Group
59
Wellington Management Group
Massachusetts
$1.66M -$121K -5,288 -6%
OSAM
60
O'Shaughnessy Asset Management
Connecticut
$1.63M -$52.3K -2,286 -3%
CCM
61
Cadence Capital Management
Massachusetts
$1.63M -$2.45M -106,980 -58%
Comerica Bank
62
Comerica Bank
Texas
$1.46M +$874K +38,175 +127%
Prudential Financial
63
Prudential Financial
New Jersey
$1.4M -$983K -42,941 -40%
Deutsche Bank
64
Deutsche Bank
Germany
$1.34M +$333K +14,530 +30%
CS
65
Credit Suisse
Switzerland
$1.3M -$541K -23,636 -28%
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$1.3M -$199K -8,700 -13%
CIP
67
Convergence Investment Partners
Florida
$1.25M +$406K +17,728 +43%
SDIC
68
South Dakota Investment Council
South Dakota
$1.21M +$1.3M +56,800 New
ZIM
69
Zacks Investment Management
Illinois
$1.19M -$123K -5,355 -9%
California Public Employees Retirement System
70
California Public Employees Retirement System
California
$1.18M +$517K +22,600 +69%
Public Sector Pension Investment Board (PSP Investments)
71
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.17M -$231K -10,100 -16%
California State Teachers Retirement System (CalSTRS)
72
California State Teachers Retirement System (CalSTRS)
California
$1.15M +$13.9K +606 +1%
RFC
73
Regions Financial Corp
Alabama
$1.09M +$47.1K +2,059 +4%
Axa
74
Axa
France
$1.07M +$126K +5,500 +12%
VRS
75
Virginia Retirement Systems
Virginia
$1.01M -$25.2K -1,100 -2%
1 2
3
4 5

EBS Hedge Fund Activity: Q3 2014 in Review

162 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2014, worth a combined $629M — down 3.9% from $655M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new EBS positions and 14 closed out — a net gain of 2 holders — while 57 added to existing stakes and 57 trimmed.

The largest buyer was Fiduciary Management Associates, opening a new position worth an estimated $14.9M. The largest seller was Numeric Investors, exiting entirely with an estimated $14.3M sold.

  • 162 institutional investors held Emergent Biosolutions (EBS) as of Q3 2014, up from 160 in Q2 2014.
  • Funds reported $629M of Emergent Biosolutions stock for Q3 2014, down 3.9% quarter-over-quarter.
  • 16 funds opened new Emergent Biosolutions positions in Q3 2014 and 14 closed out, a net change of +2 holders.
  • The largest Emergent Biosolutions buyer in Q3 2014 was Fiduciary Management Associates, an estimated $14.9M added.
  • The largest Emergent Biosolutions seller in Q3 2014 was Numeric Investors, an estimated $14.3M sold.

Based on aggregated 13F filings for Q3 2014.